speaker profile

Thomas Ogorka

Founder & CEO, Orphan Reach

Cambridge Rare Disease Network - RAREsummit19 | Thomas Ogorka 1

Moderated Discussion: Disruptive innovation and transformation – Patients at the heart of the drug development process

Bio: Thomas is the founder and CEO of Orphan Reach, previously known as QED Clinical Services. Orphan Reach is a boutique contract research organization purely focused on developing new rare disease therapies for the biotech industry. Prior to establishing Orphan Reach, he held senior management and sales & marketing positions in the international CRO industry. Thomas started his pharmaceutical career as sales representative for Sanofi-Aventis and Schering.


Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

CRDN sign up to newsletter

Sign up to our monthly newsletter packed with news & events. Join our thriving rare disease community.


You have Successfully Subscribed!